logo
Meta investors settlement with Zuckerberg takes heat off Delaware

Meta investors settlement with Zuckerberg takes heat off Delaware

The Star4 days ago
FILE PHOTO: Meta Platforms CEO Mark Zuckerberg departs after attending a Federal Trade Commission trial at U.S. District Court in Washington, D.C., U.S., April 15, 2025. REUTERS/Nathan Howard/File Photo
WILMINGTON, Delaware (Reuters) -A last-minute settlement between Meta Platforms shareholders and the company's leadership last week ended an $8 billion trial and spared Mark Zuckerberg from testifying about alleged violations of Facebook users' data. It also took the heat off the state of Delaware, which has been plagued by criticism from technology and business leaders.
The second day of the eight-day trial in Delaware's Court of Chancery was about to start on Thursday when the legal team for the shareholder plaintiffs announced they had reached a deal to resolve the case.
The terms are still being hammered out, but the agreement ends a case that had the potential to fuel a trend of companies abandoning the state as their legal home.
Since last year, Elon Musk and other business leaders have attacked the state's courts, once the key reason companies incorporated in Delaware, for rulings that they say made it easier for shareholders to sue directors.
Musk encouraged companies to leave the state and in the past year Dropbox, Trump Media & Technology, Roblox and Simon Property Group were among the large public companies that reincorporated outside Delaware, a trend dubbed "Dexit."
Critics claim the state's courts are biased against company founders-- an uncomfortable backdrop for the Meta case, whose 11 defendants included the billionaires Zuckerberg, Sheryl Sandberg, Marc Andreessen, Palantir Technologies co-founder Peter Thiel and Reed Hastings, who co-founded Netflix.
A ruling that spared the defendants might have given the impression the court caved to pressure to let them off the hook, while one that favored the plaintiffs could have led to further calls for companies to leave Delaware.
"It was going to be really awkward for the court," said Ann Lipton, a professor at Colorado Law School.
Meta, which owns Facebook, Instagram and WhatsApp, and lawyers for Meta investors and the defendants did not respond to requests for comment.
Meta shareholders alleged current and former officers and directors of Facebook were liable for failing to protect users' data. The shareholder plaintiffs wanted the court to order the defendants to use their personal fortune to reimburse the company for the $8 billion in legal costs that Facebook had shelled out for violating user privacy, including a $5 billion fine paid to the Federal Trade Commission in 2019.
The case put a spotlight on Delaware courts and the judge handling the case, Chancellor Kathaleen McCormick, who gained prominence last year for rescinding Musk's $56 billion pay package from Tesla. That ruling is on appeal.
Adding to the high stakes, Andreessen's venture capital firm, Andreessen Horowitz, said earlier this month it was moving its incorporation to Nevada from Delaware and encouraged other companies to follow. "In particular, Delaware courts can at times appear biased against technology startup founders and their boards," said a blog post on the firm's website, citing McCormick's Musk pay ruling. The firm did not respond to a request for comment.
Earlier this year, representatives from Meta met with Delaware's governor and soon after the state changed its widely used corporate law to make it harder for shareholders to sue corporate boards over deals with controlling shareholders like Zuckerberg.
Delaware's political leaders said the changes were meant to keep Meta and other companies from fleeing the state. Delaware gets more than a quarter of its budget revenue from fees associated with chartering businesses.
Despite the new law, some companies, like Affirm Holdings, still opted to leave, saying it was unclear how it would be interpreted by Delaware courts.
Lawrence Cunningham, directorof the Weinberg Center for Corporate Governance in Delaware, said the Meta shareholder settlement highlighted the strengths of the Delaware court in handling a complicated case and guiding it to a resolution, which might be hard to replicate elsewhere. "It was a very desired judicial outcome," he said of the case.
(Reporting by Tom Hals in Wilmington, Delaware; Editing by Noeleen Walder and Daniel Wallis)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

Malaysian Reserve

time5 hours ago

  • Malaysian Reserve

Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

INDIANAPOLIS, July 25, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc. (Nasdaq: VERV). Verve is a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease. 'This acquisition unlocks the opportunity to potentially transform the treatment paradigm for millions of patients worldwide by delivering lifelong cardiovascular risk reduction with a one-and-done treatment,' said Ruth Gimeno, Lilly group vice president, Diabetes and Metabolic Research and Development. 'We are excited to welcome Verve colleagues to Lilly and work together to develop innovative genetic medicines for cardiometabolic disease.' About LillyLilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit and or follow us on Facebook, Instagram, and LinkedIn. F-LLY Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements regarding Lilly's acquisition of Verve, regarding prospective benefits of the acquisition and Verve's gene editing programs for cardiovascular disease, regarding Verve's product candidates and ongoing clinical and preclinical development, and regarding Lilly's development of programs for cardiovascular disease and advancement of cardiometabolic health medicines. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements reflect current beliefs and expectations; however, these statements involve inherent risks and uncertainties, including with respect to drug research, development and commercialization, Lilly's evaluation of the accounting treatment of the acquisition and its potential impact on its financial results and financial guidance, regulatory changes and developments, the impact of global macroeconomic conditions, including trade and other global disputes and interruptions, including related to tariffs, trade protection measures, and similar restrictions, risks that the acquisition disrupts current plans and operations or adversely affect employee retention, and any legal proceedings that have been or may be instituted related to the acquisition. Actual results could differ materially due to various factors, risks and uncertainties. Among other things, there can be no guarantee that Lilly will realize the expected benefits of the acquisition, that product candidates will be approved on anticipated timelines or at all, that any products, if approved, will be commercially successful, that all or any of the contingent consideration will become payable on the terms described herein or at all, that Lilly's financial results will be consistent with its expected 2025 guidance or that Lilly can reliably predict the impact of the acquisition on its financial results or financial guidance. For further discussion of these and other risks and uncertainties, see Lilly's most recent Form 10-K and Form 10-Q filings with the U.S. Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this press release. Refer to: Ashley Hennessey; gentry_ashley_jo@ 317-416-4363 (Media) Michael Czapar; czapar_michael_c@ 317-617-0983 (Investors)

Tesla tops Chinese rivals in assisted driving tests
Tesla tops Chinese rivals in assisted driving tests

The Sun

time7 hours ago

  • The Sun

Tesla tops Chinese rivals in assisted driving tests

BEIJING: Billionaire Elon Musk's Tesla outperformed Chinese rivals including BYD, Xiaomi and Huawei in a test of assisted driving technologies on China's highways, according to results published by TikTok owner Bytedance's auto unit Dcar. State television CCTV and Dcar jointly tested the level 2 advanced driving assistance systems (ADAS) from more than 20 electric vehicle brands in China and rated their performance in a series of scenarios with higher risks of accidents on highways and urban traffics. The test videos posted by Dcar went viral on Chinese social media. Tesla scored the best in the highway test among 36 models, with its Model 3 and Model X passing five out of six scenarios, while BYD's Denza Z9GT and Huawei-backed Aito M9 failed in three scenarios. Xiaomi's SU7 passed in one of six. In a Weibo post on Friday, HIMA, the Huawei-led auto alliance, said it declined to comment on the 'so-called test.' BYD and Xiaomi didn't immediately respond to requests for comment. 'Due to laws against data export, Tesla achieved the top results in China despite having no local training data,' Tesla CEO Elon Musk said on his X account on Friday. Tesla has been caught in what Musk described as a 'quandary', as the U.S. doesn't allow its AI software to be trained in China, while the automaker has been seeking approval from Chinese regulators to transfer data saved locally in Shanghai back to the United States for algorithm training. Domestic brands should face up to the gap with Tesla in autonomous driving, Wang Yao, deputy chief engineer of the China Association of Automobile Manufacturers, told an auto forum in Shanghai earlier this month. Xiaomi CEO Lei Jun, in remarks after a Tesla Model Y delivered itself from an Austin, Texas factory to its owner in the area roughly 30 minutes away, said 'we will continue to learn' from Tesla which has led industry trends. The test came amid growing safety concerns in China about the ADAS after a highway accident involving a Xiaomi SU7 killed three people in March. State media have blamed misleading promotions for resulting drivers' improper uses of the technologies and the authorities have banned the uses of terms such as 'smart driving' and 'autonomous driving' for marketing driving assistance features. The public security ministry said this week that the country will set out legal responsibilities related to the technology that has yet achieved true autonomous driving. Drivers face safety and legal risks if they are distracted in accidents when assisted driving is turned on, the ministry warned. Xiaomi had seen a slump in new EV orders as a consumer backlash began in April following the fatal trash, but the impact seems short-lived, with its new electric SUV receiving exceptionally strong initially orders after it went on sale last month. Tesla's sales of its China-made electric vehicles edged up 0.8% in June from a year earlier, snapping an eight-month losing streak, but they continued to fall on a quarterly basis in the face of lower-cost new models from its Chinese rivals. Tesla's assisted driving suite is available in China for nearly $9,000, while the technology from its local rivals including Xiaomi and BYD is without extra cost, pressuring the U.S. automaker's self-driving future. Tesla's technology approach relies solely on cameras as sensors and artificial intelligence while most Chinese peers including BYD use lidar (light detection and range sensors) additionally to ensure performance. ($1 = 7.1624 Chinese yuan renminbi) - Reuters

Meta to halt political advertising in EU from October, blames EU rules
Meta to halt political advertising in EU from October, blames EU rules

The Star

time10 hours ago

  • The Star

Meta to halt political advertising in EU from October, blames EU rules

BRUSSELS (Reuters) -Meta Platforms will end political, electoral, social issue advertising on its platform in the European Union in early October because of the legal uncertainties due to EU rules targeting political advertising, the U.S. social media company said on Friday. Meta's announcement echoed Alphabet unit Google's decision announced last November, underscoring Big Tech's pushback against EU rules aimed at reining in their power and making sure that they are more accountable and transparent. The European Union legislation, called the Transparency and Targeting of Political Advertising (TTPA) regulation and which will apply from Oct. 10, was triggered by concerns about disinformation and foreign interference in elections across the 27-country bloc. The EU law requires Big Tech companies to clearly label political advertising on their platforms, who paid for it and how much as well as which elections are being targeted or risk fines up to 6% of their annual turnover. "From early October 2025, we will no longer allow political, electoral and social issue ads on our platforms in the EU," Meta said in a blog post. "This is a difficult decision - one we've taken in response to the EU's incoming Transparency and Targeting of Political Advertising (TTPA) regulation, which introduces significant operational challenges and legal uncertainties," it said. Meta said TTPA obligations create what it said is an untenable level of complexity and legal uncertainty for advertisers and platforms operating in the EU. It said the EU rules will ultimately hurt Europeans. "We believe that personalised ads are critical to a wide range of advertisers, including those engaged on campaigns to inform voters about important social issues that shape public discourse," Meta said. "Regulations, like the TTPA, significantly undermine our ability to offer these services, not only impacting effectiveness of advertisers' outreach but also the ability of voters to access comprehensive information," the company added. (Reporting by Foo Yun Chee, Editing by Charlotte Van Campenhout)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store